Search

Your search keyword '"McCutchan Ja"' showing total 395 results

Search Constraints

Start Over You searched for: Author "McCutchan Ja" Remove constraint Author: "McCutchan Ja"
395 results on '"McCutchan Ja"'

Search Results

1. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

2. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

3. Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

4. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment

5. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors

6. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

7. Progressive Cerebral Volume Loss in Human Immunodeficiency Virus Infection: A Longitudinal Volumetric Magnetic Resonance Imaging Study

8. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group.

9. Magnetic Resonance Imaging Morphometric Analysis of Cerebral Volume Loss in Human Immunodeficiency Virus Infection

10. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group.

11. Asymptomatic Malaria Co-infection of HIV-Infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood, and Biomarkers of Systemic Inflammation

12. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy

13. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

14. Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners

15. COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk for Neurocognitive Impairment in Men Living with HIV

16. White matter damage, neuroinflammation, and neuronal integrity in HAND

17. Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria

18. Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study

19. A-03 Ethnic/Racial Differences in Longitudinal Neurocognitive Change among People Living with HIV

20. Neurocognitive impairment in HIV-infected individuals with previous syphilis

21. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment

22. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

23. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

24. Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

25. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

26. Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder

27. Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy

28. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

29. The concomitant use of second generation antipsychotics and long term antiretroviral therapy may be associated with increased cardiovascular risk

30. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

31. Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans

32. Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma - Method-comparison evaluations

33. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

34. Neurocognitive Impairment Is an Independent Risk Factor for Death in HIV Infection

35. Azithromycin in the prophylaxis of opportunistic infections in AIDS

36. Apolipoprotein E4 Genotype Does Not Increase Risk of HIV-associated Neurocognitive Disorders

37. Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-associated Neurocognitive Disorders in the CHARTER Cohort

38. Stress and Depressive Symptoms Prospectively Predict Immune Change among HIV-Seropositive Men

39. Clinical Impact of Cytomegalovirus Infections of the Nervous System in Patients with AIDS

40. Cytomegalovirus Infections of the Nervous System in Patients with AIDS

41. Validity of the Quality of Well-Being Scale for Persons With Human Immunodeficiency Virus Infection

42. Prevalence and risk factors for HIV CSF Viral Escape: Results from the CHARTER and HNRP cohorts

43. Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS

44. Neuroleptic Treatment of HIV-Associated Psychosis

45. Expression of mannose binding lectin in HIV-1-infected brain: Implications for HIV-related neuronal damage and neuroaids

46. Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons

47. Identification of Psychobiological Stressors Among HIV-Positive Women

48. Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages

49. A factor analysis of the Klein sexual orientation Grid in two disparate samples

50. Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment

Catalog

Books, media, physical & digital resources